Portable Ultrasound to Predict Heart Failure Readmission Risk
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this research is to use a handheld ultrasound to assess patients with congestive heart failure (CHF) to see if the ultrasound can help predict readmission to the hospital. The study will include patients who are admitted to the hospital for CHF. Participants will have two ultrasounds at hospital discharge and at a follow up visit.
Full description
The purpose of this research is to see if a portable ultrasound can help predict readmission to the hospital for patients who are admitted to the hospital for CHF. The study will enroll patients who take part in Mobile Integrated Healthcare as part of their routine care. Participants will have two ultrasounds. The first ultrasound will be at hospital discharge.
Between seven to ten days after hospital discharge participants will be visited at their home in follow-up as the usual standard of care for Mobile Integrated Healthcare. At this visit participants will have a second ultrasound. Participants will be followed for one year for hospital readmission.
Sex
Ages
Volunteers
Inclusion criteria
- Primary admission diagnosis is listed as congestive heart failure, with an acute component of decompensation.
- Age greater than 18 years.
- Principal residence within the geographic reach of our MIH program.
Exclusion criteria
- pregnant women
Trial design
Primary purpose
Allocation
Interventional model
Masking
0 participants in 1 patient group
Trial contacts and locations
Loading...
Central trial contact
Zachary Dewar, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal